Studying at the University of Verona

This information is intended exclusively for students already enrolled in this course.
If you are a new student interested in enrolling, you can find information about the course of study on the course page:

Laurea magistrale a ciclo unico in Odontoiatria e protesi dentaria - Enrollment from 2025/2026

The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.

1° Year

ModulesCreditsTAFSSD
10
A
BIO/16
7
A
BIO/10
6
A
FIS/07
13
A/B/C
INF/01 ,MED/01 ,MED/02 ,M-PED/03 ,M-PSI/01
7
A
BIO/17

2° Year  activated in the A.Y. 2021/2022

ModulesCreditsTAFSSD
7
A
BIO/10
9
A
BIO/09
13
B
MED/04 ,MED/07 ,MED/42
20
B/C/F
- ,INF/01 ,MED/28 ,MED/43 ,MED/50

3° Year  activated in the A.Y. 2022/2023

ModulesCreditsTAFSSD
7
B
BIO/14
14
B/C/F
- ,BIO/12 ,MED/09 ,MED/30

4° Year  activated in the A.Y. 2023/2024

ModulesCreditsTAFSSD
5
B/F
- ,MED/28
3
B/F
- ,MED/28
4
B/F
- ,MED/25 ,MED/26
13
B/F
- ,MED/18 ,MED/35 ,MED/41

5° Year  activated in the A.Y. 2024/2025

ModulesCreditsTAFSSD
12
B/F
- ,MED/28
7
B/F
- ,MED/28 ,MED/38
12
B/F
- ,MED/28
8
B/F
- ,MED/28
6
B/F
- ,MED/28
10
B/C/F
- ,MED/28 ,MED/29 ,MED/31

6° Year  It will be activated in the A.Y. 2025/2026

ModulesCreditsTAFSSD
Final exam
10
E
-
activated in the A.Y. 2021/2022
ModulesCreditsTAFSSD
7
A
BIO/10
9
A
BIO/09
13
B
MED/04 ,MED/07 ,MED/42
20
B/C/F
- ,INF/01 ,MED/28 ,MED/43 ,MED/50
activated in the A.Y. 2022/2023
ModulesCreditsTAFSSD
7
B
BIO/14
14
B/C/F
- ,BIO/12 ,MED/09 ,MED/30
activated in the A.Y. 2023/2024
ModulesCreditsTAFSSD
5
B/F
- ,MED/28
3
B/F
- ,MED/28
4
B/F
- ,MED/25 ,MED/26
13
B/F
- ,MED/18 ,MED/35 ,MED/41
activated in the A.Y. 2024/2025
ModulesCreditsTAFSSD
12
B/F
- ,MED/28
7
B/F
- ,MED/28 ,MED/38
12
B/F
- ,MED/28
8
B/F
- ,MED/28
6
B/F
- ,MED/28
10
B/C/F
- ,MED/28 ,MED/29 ,MED/31
It will be activated in the A.Y. 2025/2026
ModulesCreditsTAFSSD
Final exam
10
E
-

Legend | Type of training activity (TTA)

TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.




S Placements in companies, public or private institutions and professional associations

Teaching code

4S02656

Credits

6

Language

Italian

Scientific Disciplinary Sector (SSD)

MED/04 - EXPERIMENTAL MEDICINE AND PATHOPHYSIOLOGY

Period

LEZIONI 2°SEMESTRE  dal Feb 14, 2022 al May 27, 2022.

To show the organization of the course that includes this module, follow this link:  Course organization

Learning outcomes

The basic aim of the course is the acquisition of the conceptual and scientific tools to explain the causes and mechanisms of human diseases. Specifically: 1) to understand the principal chemical, physical and biological causes of cell and tissue damage; 2) to understand tissue reaction to damage, that are determinat in acute and chronic physiopathologic processes: focus on inflammation, hemostasis and tissue repair; 3) to understand aethiopathogenesis of neoplastic transformation. Particular attention will be devoted to the acquisition of scientific terms used in pathology.

Program

1. Introduction
General concepts
Homeostasis.
Pathogenesis
Etiology
Glossary

2. Cellular pathology: basic mechanisms of cellular damage; biochemical lesion.
Pathogenesis of hypoxia, ischemia and oxidative stress.
Oxygen radical-induced pathologies.
Pathogenesis of radiation damage.
Biological causes of diseases: general concepts of pathogenesis of infectious diseases. Endotoxins and exotoxins: physical-chemical features, biological effects, molecular basis.
Cellular death: necrosis. Serum markers of necrosis. Necrosis pathologist classification.

3. Introduction to the immune system: cellular composition and function.
The hematopoietic system: blood cell composition; hematocrit; leukocyte formula.
Functional and morphological features of leukocyte cell populations.
The reticulo-endothelial system.
Differentiation and maturation of the lymphoid and myeloid cell populations.
Innate and acquired immune responses: general concepts.
Inflammation: causes, cardinal signs, angiophlogosis and histoflogosis.
The vascular response. Exudate: features and functions.
The cellular response: leukocyte migration, rolling, activation, firm adhesion and diapedesis.
Adhesion molecules: selectins, integrins, immunoglobulins.
Chemotaxis and chemotactic factors.
Leukocyte effector mechanisms (phagocytosis, killing and degradation of phagocytosed microbes)
Defects of innate immune cells: LAD, CGD.
Chemical mediators and regulators of inflammation.
Coagulation; Complement; chinins, plasmin.
Cellular proinflammatory mediators: (i) preformed; (ii) newly synthesized (fast); (iii) newly synthesized (slow).
Cytokines: general concepts; cytokine families; physiological role; mechanisms of action.
Chemokines: C, CC, CXC, CX3C.
Proinflammatory cytokines: TNF alpha, IL-1, IL-6: producing cells, stimuli, biological role, local, systemic and pathologic effects.
Autoinflammatory syndromes: definition, causes, therapeutic strategies.
Inhibition of proinflammatory cytokines: IL-10 and IL-1ra. Anti-cytokine therapy in autoimmune diseases.
Cytokine response in sepsis and physical exercise.
Interferons: classes, producing cells, stimuli, biological and pathological role.
Systemic effects of inflammation.
Pathogenesis of septic shock.

4. Outcomes of acute inflammation.
Chronic inflammation. Granuloma.
Resolution: Regeneration and repair.
Scarring

5. Genoma ed epigenoma.
The "Histone code".
Non-coding RNAs.
Apoptosi: estrinsic and intrinsic pathway.

6. Mechanisms regulating cellular differentiation and proliferation: pathological changes.
Metaplasia, dysplasia and neoplasia. Neoplasia (general concepts)
Morphological, molecular, metabolic, genetic and functional features of the neoplastic cell.
Cancer etiology and pathogenesis.
Cancer natural history.
Molecular bases of carcinogenesis: proto-oncogenes, oncogenes, tumor suppressor genes. Oncogenes classes: (i) growth factors (EGF); (ii) growth factor receptors (EGFR/ErbB, Her2 receptor/Neu); (III) signal transduction proteins (ras); (IV) nuclear transcription factors (myc); (V) chromatin-associate proteins; (VI) cell cycle control; (VII) microRNA; (VIII) pro and anti-apoptotic proteins (Bcl2).
Tumor suppressor genes: Cyclins, retinoblastoma, p53: physiologic and pathologic role.
The Knudson hypothesis.
Viral carcinogenesis.
Nomenclature. The TNM system.
Benign and malignant hematologic neoplasia.
Head and neck cancer.
Metastasis: molecular basis of metastasis generation ad progression.
Neoplastic cachexia and paraneoplastic syndromes.
Tumor immunology.

Bibliography

Visualizza la bibliografia con Leganto, strumento che il Sistema Bibliotecario mette a disposizione per recuperare i testi in programma d'esame in modo semplice e innovativo.

Examination Methods

oral examination

Students with disabilities or specific learning disorders (SLD), who intend to request the adaptation of the exam, must follow the instructions given HERE